Osiris Therapeutics, Inc. (OSIR) To Present At The Canaccord Genuity Musculoskeletal Conference
3/10/2014 6:29:33 AM
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2014 Canaccord Genuity Musculoskeletal Conference on Tuesday, March 11, 2014 at 2:20 p.m. ET (1:20 a.m. CT) in New Orleans.
Help employers find you! Check out all the jobs and post your resume.
comments powered by